Beta-acetyldigoxin is a cardiac glycoside closely related to digoxin and is used for its positive inotropic effect on the heart. It works by inhibiting the sodium–potassium ATPase pump, leading to increased intracellular calcium in cardiac muscle. This action results in stronger and more efficient heart contractions. Beta-acetyldigoxin is mainly used in the management of congestive heart failure. It is also effective in controlling certain supraventricular arrhythmias, such as atrial fibrillation. The drug helps improve cardiac output and reduce symptoms like edema and shortness of breath. It has a narrow therapeutic index, requiring careful dose adjustment. Regular monitoring is important to prevent toxicity and adverse effects. Beta-acetyldigoxin is usually administered orally and shows good bioavailability. Overall, it plays an important role in the long-term management of cardiac disorders.
